샘플 요청 목록

 카트 문의
시장보고서
상품코드
1579674

혈당 측정기 시장

Blood Glucose Meters
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 91 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 혈당 측정기 시장은 2030년까지 501억 달러에 달할 것으로 전망

2023년 318억 달러로 추정되는 혈당 측정기 세계 시장은 2030년에는 501억 달러에 달할 것으로 예상되며, 2023-2030년간 6.7%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. 이 보고서에서 분석한 부문 중 하나인 자가 혈당 측정기는 CAGR 6.4%를 기록하여 분석 기간이 끝날 때까지 368억 달러에 도달할 것으로 예상됩니다. 지속적인 혈당 측정기 부문의 성장률은 분석 기간 동안 CAGR 7.6%로 추정됩니다.

미국 시장은 86억 달러로 추정, 중국은 CAGR 10.8%로 성장 전망

미국 혈당 측정기 시장은 2023년 86억 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2023-2030년간 10.8%의 연평균 복합 성장률(CAGR)로 2030년까지 시장 규모가 114억 달러에 달할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 2.5%와 7.0%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. 유럽에서는 독일이 연평균 3.8%의 성장률을 보일 것으로 예상됩니다.

세계 혈당 측정기 시장 - 주요 동향 및 촉진요인 요약

혈당 측정기가 당뇨병 관리에 필수적인 이유는 무엇인가?

혈당 측정기는 혈당 수치를 측정하고 모니터링하도록 설계된 소형 휴대용 의료기기로, 당뇨병을 관리하는 개인에게 중요한 정보를 제공합니다. 혈당 측정기의 주요 구성 요소는 란셋 장치, 테스트 스트립 및 디지털 미터 자체입니다. 먼저 랜싯으로 손가락 끝을 찔러 혈액 한 방울을 채취합니다. 포도당 산화 효소 및 포도당 탈수소 효소와 같은 효소로 코팅 된 스트립은 혈액 샘플과 반응하여 혈액 내 포도당 농도에 비례하는 전기 신호를 생성합니다. 이 신호는 미터로 전송되고 미터는 지역 표준에 따라 데시리터 당 밀리그램(mg/dL) 또는 리터당 밀리몰(mmol/L)로 혈당치를 계산하고 표시합니다. 최신 혈당 측정기는 전기 화학 센서 및 광학 센서와 같은 고급 바이오 센싱 기술을 사용하여 측정의 정확성과 속도를 높이고 종종 몇 초 이내에 결과를 제공합니다. 또한 많은 측정기는 메모리 저장, 데이터 추적, 블루투스 연결 등의 기능을 갖추고 있어 사용자가 포도당 측정값을 저장하고 의료 전문가와 공유하여 보다 종합적인 당뇨병 관리를 할 수 있습니다. 센서 기술과 소형화의 지속적인 발전으로 제조업체는 더 적은 양의 혈액 샘플로 측정기를 생산할 수 있게 되어 불편함을 최소화하고 빈번한 검사를 더 편리하게 할 수 있게 되었습니다.

혈당 측정기가 당뇨병 관리에 필수적인 이유는 무엇인가?

혈당 측정기는 당뇨병 관리에 필수적입니다. 혈당 측정기는 개인의 혈당 수치를 실시간으로 파악할 수 있어 당뇨병 상태를 사전에 관리하고 합병증 위험을 줄일 수 있기 때문입니다. 당뇨병은 인슐린 생산 또는 이용 장애를 특징으로 하는 만성 질환으로, 혈당 수치가 상승하고 관리하지 않으면 심혈관 질환, 신경 장애, 신장 장애, 시력 장애와 같은 심각한 건강 문제를 일으킬 수 있습니다. 따라서 당뇨병 환자에게 혈당을 정기적으로 모니터링하는 것은 목표 범위를 유지하고 고혈당(고혈당)과 저혈당(저혈당)을 예방하는 데 필수적입니다. 혈당 측정기는 사용자가 자신의 포도당 패턴을 추적하고 식사 섭취, 신체 활동, 스트레스, 약물 복용과 같은 다양한 요인이 혈당에 어떤 영향을 미치는지 이해할 수 있도록 도와줍니다. 이 지식을 통해 인슐린 용량, 식단 선택 및 생활 습관을 적시에 조정하여 더 나은 혈당 조절을 촉진하고 장기적인 합병증의 가능성을 줄일 수 있습니다. 또한 혈당 측정기는 인슐린 투여량과 투여 시기를 미세 조정하는 데 필요한 데이터를 제공하기 때문에 집중적인 인슐린 치료를 받고 있는 환자들에게 필수적입니다. 의료 서비스 제공업체에게는 환자의 경과를 모니터링하고 치료 계획과 관련하여 근거에 기반한 결정을 내릴 수 있는 신뢰할 수 있는 수단을 제공합니다. 디지털 통합 스마트 혈당 측정기의 도입으로 이러한 기기의 역할이 더욱 강화되어 혈당 데이터를 의료진과 원활하게 공유하고 원격 의료 이니셔티브를 지원할 수 있게 되었습니다.

혈당 측정기의 미래는 어떤 혁신으로 형성되고 있는가?

최근의 기술 혁신은 보다 정확하고, 보다 침습적이지 않으며, 보다 디지털 건강 플랫폼과 통합된 기기를 통해 혈당 모니터링의 상황을 변화시키고 있습니다. 가장 주목할 만한 발전 중 하나는 연속 혈당 모니터링(CGM) 시스템의 개발입니다. CGM 시스템은 피하에 부착하는 소형 센서를 통해 밤낮을 가리지 않고 실시간 혈당 측정값을 제공하는데, 손가락을 자주 찔러야 하는 번거로움을 없애고 혈당 추이를 보다 종합적으로 파악할 수 있게 해줍니다. 혈당 추이를 보다 종합적으로 파악할 수 있어 잠재적인 고혈당이나 저혈당이 발생하기 전에 사용자에게 경고합니다. 또한 기존 혈당 측정기에 스마트 기술을 통합하여 기능성과 사용자 경험을 향상시켰으며, 블루투스 및 클라우드 연결 기능을 갖춘 스마트 미터를 통해 사용자는 측정값을 모바일 앱에 동기화하여 상세한 분석, 추세 시각화 및 개인 맞춤형 피드백을 제공할 수 있습니다. 개인 맞춤형 피드백을 제공할 수 있습니다. 일부 고급 모델에는 포도당 데이터를 분석하고 변동을 예측하는 인공지능(AI) 알고리즘이 내장되어 있어 사용자가 변화를 예측하고 그에 따라 관리 전략을 조정할 수 있도록 돕습니다. 또 다른 획기적인 혁신은 광학 센서나 전자기 분광법과 같은 비침습적 포도당 모니터링 기술의 등장입니다. 이러한 기술은 혈액을 채취할 필요 없이 피부나 기타 체액을 통해 포도당 수치를 측정하는 것을 목표로 합니다. 아직 개발 중이지만, 이러한 기술은 기존 검사 방법의 고통과 불편함을 크게 줄임으로써 혈당 모니터링에 혁명을 가져올 것으로 기대되고 있습니다. 또한, 일회용 마이크로 바늘과 레이저 기반 센서의 사용은 채혈의 불편함을 줄일 수 있다는 점에서 주목을 받고 있습니다. 바이오센서 기술의 발전으로 케톤체나 젖산과 같은 추가 바이오마커를 측정할 수 있는 다항목 측정기가 개발되어 환자의 대사 상태를 보다 종합적으로 파악할 수 있게 되었습니다.

혈당 측정기 시장의 성장 촉진요인은 무엇인가?

혈당 측정기 시장의 성장은 전 세계 당뇨병 유병률 증가, 자가 모니터링 관행에 대한 인식 증가, 포도당 모니터링 기술의 지속적인 발전 등 여러 요인에 의해 주도되고 있습니다. 주요 요인 중 하나는 당뇨병, 특히 제 2 형 당뇨병의 유병률 증가이며, 이는 비만, 식습관 장애, 운동 부족과 같은 생활 습관과 관련이 있습니다. 국제당뇨병연맹에 따르면 현재 5억 3,700만 명 이상의 성인이 당뇨병을 앓고 있으며, 이 숫자는 향후 수십년동안 크게 증가할 것으로 예상됩니다. 정기적인 모니터링은 당뇨병 관리의 핵심이기 때문에 이러한 환자 수 증가는 효과적인 혈당 모니터링 솔루션에 대한 수요를 촉진하고 있습니다. 또 다른 시장 성장의 또 다른 요인은 예방적 건강관리와 자가 관리에 대한 중요성이 높아지고 있다는 점입니다. 각국 정부와 의료 기관은 당뇨병 교육 프로그램의 일환으로 혈당 측정기 사용을 장려하고 조기 발견과 더 나은 질병 관리를 장려하여 의료 시스템의 부담을 줄이고 있습니다. 스마트 혈당 측정기 및 연속 혈당 모니터링 시스템 개발과 같은 기술적 발전은 혈당 모니터링을 보다 친숙하고 정확하며 사용자 친화적으로 만들어 시장 확대에 기여하고 있습니다. 이러한 기기는 자동 데이터 로깅, 클라우드 기반 공유, 인슐린 펌프와의 통합과 같은 기능을 제공하여 보다 종합적인 당뇨병 관리를 지원하고 환자의 순응도를 향상시킵니다. 또한 원격 의료 및 디지털 건강 플랫폼의 확대로 원격 모니터링이 당뇨병 치료의 일반적인 요소가 되어 혈당 측정기에 새로운 비즈니스 기회를 제공합니다. 또한, 신흥 시장의 가처분 소득 증가와 의료 인프라 개선으로 인해 고급 혈당 측정기의 가격이 저렴해져 더 많은 소비자들이 이용할 수 있게 되었습니다. 이들 지역에서는 혈당 측정기 및 테스트 스트립의 저가형 모델과 상환 정책의 도입이 시장 침투를 더욱 촉진하고 있습니다. 이러한 요인들이 결합되어 혈당 측정기 채택이 증가하고 있을 뿐만 아니라, 보다 정교하고 연결된 환자 중심적인 솔루션으로 시장이 진화하고 있습니다.

조사 대상 기업 예시(총 38건)

  • Abbott
  • Ascensia Diabetes Care Holdings AG.
  • Braun Melsungen AG
  • DiaMonTech GmbH
  • Dexcom, Inc.
  • Hoffmann-La Roche Ltd.
  • Lifespan Inc.
  • Medtronic
  • Sanofi
  • Terumo Medical Corporation

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 24.11.01

Global Blood Glucose Meters Market to Reach US$50.1 Billion by 2030

The global market for Blood Glucose Meters estimated at US$31.8 Billion in the year 2023, is expected to reach US$50.1 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2023-2030. Self-Monitoring Blood Glucose Meters, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$36.8 Billion by the end of the analysis period. Growth in the Continuous Blood Glucose Meters segment is estimated at 7.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.6 Billion While China is Forecast to Grow at 10.8% CAGR

The Blood Glucose Meters market in the U.S. is estimated at US$8.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$11.4 Billion by the year 2030 trailing a CAGR of 10.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Blood Glucose Meters Market - Key Trends and Drivers Summarized

Why Are Blood Glucose Meters Indispensable in Diabetes Management?

Blood glucose meters are compact, portable medical devices designed to measure and monitor blood sugar levels, providing critical information for individuals managing diabetes. The primary components of a blood glucose meter include a lancet device, test strips, and the digital meter itself. The process begins by using the lancet to prick the fingertip, producing a small drop of blood that is then applied to a test strip. The strip, coated with enzymes like glucose oxidase or glucose dehydrogenase, reacts with the blood sample, generating an electrical signal proportional to the glucose concentration in the blood. This signal is transmitted to the meter, which calculates and displays the blood glucose level in milligrams per deciliter (mg/dL) or millimoles per liter (mmol/L), depending on regional standards. Modern blood glucose meters use advanced biosensing technologies, such as electrochemical and optical sensors, to enhance the accuracy and speed of readings, often delivering results within seconds. Additionally, many meters are equipped with features like memory storage, data tracking, and Bluetooth connectivity, allowing users to store and share their glucose readings with healthcare professionals for more comprehensive diabetes management. Continuous developments in sensor technology and miniaturization have enabled manufacturers to produce meters that require smaller blood samples, minimizing discomfort and making frequent testing more convenient.

Why Are Blood Glucose Meters Essential for Diabetes Care?

Blood glucose meters are crucial for diabetes care because they provide real-time insights into an individual’s blood sugar levels, enabling proactive management of the condition and reducing the risk of complications. Diabetes is a chronic condition characterized by impaired insulin production or utilization, leading to elevated blood glucose levels that can result in serious health issues such as cardiovascular disease, neuropathy, kidney damage, and vision impairment if left unmanaged. Regular monitoring of blood glucose levels is therefore vital for individuals with diabetes to maintain target ranges and prevent both hyperglycemia (high blood sugar) and hypoglycemia (low blood sugar). Blood glucose meters empower users to track their glucose patterns and understand how various factors like food intake, physical activity, stress, and medications affect their blood sugar levels. This knowledge allows for timely adjustments in insulin doses, dietary choices, and lifestyle habits, promoting better glycemic control and reducing the likelihood of long-term complications. Additionally, blood glucose meters are indispensable for patients on intensive insulin therapy, as they provide the necessary data to fine-tune insulin dosages and timing. For healthcare providers, these devices offer a reliable means of monitoring patient progress and making evidence-based decisions regarding treatment plans. The introduction of smart glucose meters with digital integration has further enhanced the role of these devices, allowing seamless sharing of glucose data with healthcare teams and supporting telehealth initiatives.

What Innovations Are Shaping the Future of Blood Glucose Meters?

Recent innovations are transforming the landscape of blood glucose monitoring by making devices more accurate, less invasive, and more integrated with digital health platforms. One of the most notable advancements is the development of continuous glucose monitoring (CGM) systems, which provide real-time glucose readings throughout the day and night using a small sensor placed under the skin. CGM systems eliminate the need for frequent finger pricks and offer a more comprehensive view of glucose trends, alerting users to potential highs and lows before they occur. Additionally, the integration of smart technology in traditional blood glucose meters is enhancing functionality and user experience. Smart meters equipped with Bluetooth and cloud connectivity allow users to sync their readings to mobile apps, providing detailed analytics, trend visualization, and personalized feedback. Some advanced models are incorporating artificial intelligence (AI) algorithms that analyze glucose data and predict fluctuations, helping users anticipate changes and adjust their management strategies accordingly. Another groundbreaking innovation is the emergence of non-invasive glucose monitoring technologies, such as optical sensors and electromagnetic spectroscopy, which aim to measure glucose levels through the skin or other body fluids without the need for blood samples. Although still in development, these technologies promise to revolutionize blood glucose monitoring by significantly reducing the pain and inconvenience associated with traditional testing methods. Furthermore, the use of disposable micro-needles and laser-based sensors is gaining attention for their ability to reduce the discomfort of blood sampling. Advances in biosensor technology are also enabling the creation of multi-analyte meters that can measure additional biomarkers like ketones or lactate, providing a more holistic view of a patient’s metabolic state.

What Are the Key Drivers of Growth in the Blood Glucose Meter Market?

The growth in the blood glucose meter market is driven by several factors, including the rising global prevalence of diabetes, increasing awareness of self-monitoring practices, and continuous advancements in glucose monitoring technology. One of the primary drivers is the escalating incidence of diabetes, particularly type 2 diabetes, which is linked to lifestyle factors such as obesity, poor diet, and lack of physical activity. According to the International Diabetes Federation, over 537 million adults are currently living with diabetes, and this number is expected to rise significantly in the coming decades. This growing patient population is fueling demand for effective blood glucose monitoring solutions, as regular monitoring is a cornerstone of diabetes management. Another factor contributing to market growth is the increasing emphasis on preventive healthcare and self-management. Governments and healthcare organizations are promoting the use of blood glucose meters as part of broader diabetes education programs to encourage early detection and better disease management, thereby reducing the burden on healthcare systems. Technological advancements, such as the development of smart meters and continuous glucose monitoring systems, are also driving market expansion by making glucose monitoring more accessible, accurate, and user-friendly. These devices offer features like automated data logging, cloud-based sharing, and integration with insulin pumps, supporting more comprehensive diabetes management and improving patient adherence. Additionally, the expansion of telehealth and digital health platforms is creating new opportunities for blood glucose meters, as remote monitoring becomes a more common component of diabetes care. Furthermore, increasing disposable incomes and improving healthcare infrastructure in emerging markets are making advanced blood glucose meters more affordable and accessible to a broader consumer base. The introduction of low-cost models and reimbursement policies for glucose meters and test strips in these regions is further boosting market penetration. Collectively, these factors are driving not only the adoption of blood glucose meters but also the evolution of the market towards more sophisticated, connected, and patient-centric solutions.

Select Competitors (Total 38 Featured) -

  • Abbott
  • Ascensia Diabetes Care Holdings AG.
  • Braun Melsungen AG
  • DiaMonTech GmbH
  • Dexcom, Inc.
  • Hoffmann-La Roche Ltd.
  • Lifespan Inc.
  • Medtronic
  • Sanofi
  • Terumo Medical Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Blood Glucose Meters - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Diabetes Globally Propels Demand for Blood Glucose Meters
    • Increasing Adoption of Self-Monitoring Devices Expands Addressable Market for Blood Glucose Meters
    • Advances in Continuous Glucose Monitoring (CGM) Technology Drives Growth for Smart Blood Glucose Meters
    • Growing Focus on Preventive Healthcare Accelerates Demand for Home-Based Blood Glucose Monitoring
    • Integration of Wireless and Bluetooth Connectivity Strengthens the Business Case for Digital Blood Glucose Meters
    • Increased Adoption of Telemedicine and Remote Monitoring Expands Market Opportunity for Connected Glucose Meters
    • Advances in Biosensor Technologies Propel Growth in Accuracy and Precision of Blood Glucose Meters
    • Growing Demand for Portable and User-Friendly Devices Here's How It Drives Adoption of Compact Blood Glucose Meters
    • Surge in Demand for Wearable Health Devices Accelerates Growth of Integrated Blood Glucose Monitoring Solutions
    • Expansion of Digital Health Platforms Generates Opportunities for Cloud-Connected Blood Glucose Meters
    • Increasing Prevalence of Childhood Diabetes Expands the Market for Pediatric Blood Glucose Meters
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Invasive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Non-Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Non-Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Non-Invasive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Blood Glucose Meters Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Blood Glucose Meters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Blood Glucose Meters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Blood Glucose Meters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Self-Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Self-Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Self-Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Continuous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Continuous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Continuous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Personal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Personal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Personal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Blood Glucose Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Blood Glucose Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Blood Glucose Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Blood Glucose Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Blood Glucose Meters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Blood Glucose Meters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Blood Glucose Meters by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Blood Glucose Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Blood Glucose Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Blood Glucose Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Blood Glucose Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Meters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Blood Glucose Meters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Blood Glucose Meters by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Blood Glucose Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Blood Glucose Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: India 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: India 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Blood Glucose Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Blood Glucose Meters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Blood Glucose Meters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Blood Glucose Meters by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Blood Glucose Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Blood Glucose Meters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Blood Glucose Meters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Blood Glucose Meters by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Blood Glucose Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Blood Glucose Meters by Technique - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Blood Glucose Meters by Technique - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Blood Glucose Meters by Technique - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Blood Glucose Meters by Type - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Blood Glucose Meters by Type - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Blood Glucose Meters by Type - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Blood Glucose Meters by End-Use - Clinics, Hospitals, Personal and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Blood Glucose Meters by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals, Personal and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제